Blog
RSS FeedPosted by Michael Wonder on 12 Jun 2018
Trump officials meet with drug companies to push for voluntary price cuts
11 June 2018 - Department of Health and Human Services officials have been meeting with pharmaceutical companies to seek voluntary ...
Posted by Michael Wonder on 06 Jun 2018
Big pharma wants to invest more in Australian biotech says Greg Hunt
6 June 2018 - Big pharma is "looking at Australia as the next destination in the developed world, the emerging first-world ...
Posted by Michael Wonder on 06 Jun 2018
Sanofi, Merck and J&J tout lower drug prices
5 June 2018 - While a handful of drug companies say their average net prices have dropped, FDA Commissioner Scott Gottlieb ...
Posted by Michael Wonder on 05 Jun 2018
Embracing competition to empower biosimilars
5 June 2018 - In 2017, there were 46 new novel drug innovations, including new treatments for cancers, Parkinson’s disease, ...
Posted by Michael Wonder on 05 Jun 2018
FDA drafts new guidance on formal meetings between FDA, biosimilar sponsors
4 June 2018 - The US FDA has released new draft guidance on formal meetings between biosimilar sponsors and the ...
Posted by Michael Wonder on 04 Jun 2018
Two more EU Member States benefit from EU-US mutual recognition agreement for inspections
1 June 2018 - Agreement now operational between 14 EU Member States and FDA. ...
Posted by Michael Wonder on 04 Jun 2018
FDA wants to shorten new drug monopolies to cut costs
4 June 2018 - In an effort to increase competition and bring down prescription drug prices, FDA Commissioner Dr. Scott Gottlieb ...
Posted by Michael Wonder on 30 May 2018
Are big clinical trials relevant? Researchers disagree
29 May 2018 - Amid health care tailored to an individual’s DNA, do massive clinical trials that take years and involve ...
Posted by Michael Wonder on 22 May 2018
GOP chairman in talks with 'big pharma' on moving drug pricing bill
21 May 2018 - Sen. Chuck Grassley said Monday he is in talks with drug companies about a possible deal ...
Posted by Michael Wonder on 17 May 2018
Statement from FDA Commissioner on new agency efforts to shine light on situations where drug makers may be pursuing gaming tactics to delay generic competition
17 May 2018 - No patients should be priced out of medicines they need to support their health. ...
Posted by Michael Wonder on 17 May 2018
Addressing generic drug market failures - the case for establishing a non-profit manufacturer
17 May 2018 - Robust competition usually keeps the price of generic drugs well below that of brand-name drugs. When ...
Posted by Michael Wonder on 15 May 2018
FDA to name companies accused of hindering generic drug development
14 May 2018 - On Thursday, the FDA plans to start publishing the names of pharmaceutical companies that have been ...
Posted by Michael Wonder on 12 May 2018
PhRMA statement on President Trump’s drug pricing blueprint
11 May 2018 - Pharmaceutical Research and Manufacturers of America president and CEO Stephen J. Ubl issued the following statement ...
Posted by Michael Wonder on 05 May 2018
Gottlieb pushes back against criticism of ‘breakthrough’ designation
4 May 2018 - FDA Commissioner Scott Gottlieb defended his agency’s “breakthrough therapy” program, which speeds review of drugs that ...
Posted by Michael Wonder on 25 Apr 2018
Generic drug companies to face first charges in U.S. probe
25 April 2018 - Mylan headquarters searched by law enforcement in 2016. ...